Loading...
OTCM
UNVC
Market cap5mUSD
Jul 11, Last price  
0.00USD
1D
-3.10%
1Q
-18.03%
Name

Univec Inc

Chart & Performance

D1W1MN
No data to show
P/E
P/S
270.74
EPS
Div Yield, %
Shrs. gr., 5y
111.35%
Rev. gr., 5y
-0.39%
Revenues
21k
-36.55%
500,0002,428,5391,846,9493,344,5593,078,1513,905,0502,887,51016,133,65219,448,38881,39821,45714,50814,50853,68033,16521,044
Net income
-3m
L-2.59%
-1,400,000-1,172,453-1,897,206-1,158,942-2,295,683-893,780-505,082-1,545,601-4,020,536-1,889,089-1,183,067-1,108,296-1,166,450-1,339,745-2,666,076-2,597,090
CFO
-55k
L-96.89%
-1,200,000-2,285,003-1,125,764-443,744-284,531-133,732-276,243-326,146-747,984-319,482-574,36100-3,982,299-1,770,479-55,108

Profile

Univec, Inc., through its subsidiaries, produces, licenses, and markets medical products in the United States and internationally. It primarily provides auto-disable and safety syringes. The company offers 1 cc AD-syringe for aspirating and non-aspirating applications, which are used for dispensing dosages of allergy, immunization, and insulin medicines. It also manufactures and markets sliding sheath syringes that are designed to protect patients and healthcare workers from needle stick injuries; and bifurcated needle safety syringes, which are used in administering smallpox vaccines in response to bio-terrorist threats. Univec markets its auto-disable syringes and sliding sheath safety syringes to private hospitals, health facilities, and distributors in the United States, as well as to governments of developing countries. In addition, it assists pharmaceutical companies in marketing, fulfillment, and tracking drug samples via an online system connecting pharmacies and managed payment providers. The company was founded in 1992 and is based in Baltimore, Maryland.
IPO date
Apr 24, 1997
Employees
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑12
Income
Revenues
21
-36.55%
33
-38.22%
Cost of revenue
26
37
Unusual Expense (Income)
NOPBT
(4)
(4)
NOPBT Margin
Operating Taxes
(2)
2
Tax Rate
NOPAT
(4)
(4)
Net income
(2,597)
-2.59%
(2,666)
99.00%
Dividends
Dividend yield
Proceeds from repurchase of equity
1,740
BB yield
Debt
Debt current
18
13
Long-term debt
1,172
1,122
Deferred revenue
Other long-term liabilities
(1)
Net debt
1,190
1,135
Cash flow
Cash from operating activities
(55)
(1,770)
CAPEX
Cash from investing activities
Cash from financing activities
55
1,770
FCF
1,201
894
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
(32,400)
(29,803)
Invested Capital
18,518
18,463
ROIC
ROCE
0.03%
0.03%
EV
Common stock shares outstanding
2,523,097
2,523,097
Price
Market cap
EV
EBITDA
1
2
EV/EBITDA
Interest
22
13
Interest/NOPBT